92 related articles for article (PubMed ID: 17624459)
1. Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo.
Takezawa T; Takeuchi T; Nitani A; Takayama Y; Kino-Oka M; Taya M; Enosawa S
J Biotechnol; 2007 Aug; 131(1):76-83. PubMed ID: 17624459
[TBL] [Abstract][Full Text] [Related]
2. A protein-permeable scaffold of a collagen vitrigel membrane useful for reconstructing crosstalk models between two different cell types.
Takezawa T; Nitani A; Shimo-Oka T; Takayama Y
Cells Tissues Organs; 2007; 185(1-3):237-41. PubMed ID: 17587830
[TBL] [Abstract][Full Text] [Related]
3. Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2.
Zhao J; Shinkai M; Takezawa T; Ohba S; Chung UI; Nagamune T
J Biosci Bioeng; 2009 Mar; 107(3):318-23. PubMed ID: 19269600
[TBL] [Abstract][Full Text] [Related]
4. [Development of novel cell culture systems utilizing the advantages of collagen vitrigel membrane].
Takezawa T; Fukuda M; McIntosh-Ambrose W; Ko JA; Elisseeff J; Haga S; Ozaki M; Kato K; Wang PC; Uchino T; Nishida T
Yakugaku Zasshi; 2010 Apr; 130(4):565-74. PubMed ID: 20372002
[TBL] [Abstract][Full Text] [Related]
5. [Advantages of culture models utilizing substrata made of TOSHI (tissue/organ sections for histopathology) or collagen vitrigel membrane and their application concept for drug development researches].
Takezawa T; Takeuchi T; Yanagihara K; Nakazawa Y; Nitani A; Terada S; Ochiya T; Ueno K
Yakugaku Zasshi; 2008 Jan; 128(1):51-60. PubMed ID: 18176056
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of VEGF-mediated signaling in primary human cells reveals a paracrine action for VEGF in osteoblast-mediated crosstalk to endothelial cells.
Clarkin CE; Emery RJ; Pitsillides AA; Wheeler-Jones CP
J Cell Physiol; 2008 Feb; 214(2):537-44. PubMed ID: 17685428
[TBL] [Abstract][Full Text] [Related]
7. Development of a human corneal epithelium model utilizing a collagen vitrigel membrane and the changes of its barrier function induced by exposing eye irritant chemicals.
Takezawa T; Nishikawa K; Wang PC
Toxicol In Vitro; 2011 Sep; 25(6):1237-41. PubMed ID: 21641988
[TBL] [Abstract][Full Text] [Related]
8. Reconstruction of three-dimensional human skin model composed of dendritic cells, keratinocytes and fibroblasts utilizing a handy scaffold of collagen vitrigel membrane.
Uchino T; Takezawa T; Ikarashi Y
Toxicol In Vitro; 2009 Mar; 23(2):333-7. PubMed ID: 19121381
[TBL] [Abstract][Full Text] [Related]
9. Bioactivity of small intestinal submucosa and oxidized regenerated cellulose/collagen.
Nihsen ES; Johnson CE; Hiles MC
Adv Skin Wound Care; 2008 Oct; 21(10):479-86. PubMed ID: 18836327
[TBL] [Abstract][Full Text] [Related]
10. Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor.
Mao Z; Shi H; Guo R; Ma L; Gao C; Han C; Shen J
Acta Biomater; 2009 Oct; 5(8):2983-94. PubMed ID: 19406694
[TBL] [Abstract][Full Text] [Related]
11. Collagen vitrigel scaffold for regenerative medicine of the trachea: experimental study and quantitative evaluation.
Tada Y; Takezawa T; Tani A; Nakamura T; Omori K
Acta Otolaryngol; 2012 Apr; 132(4):447-52. PubMed ID: 22443856
[TBL] [Abstract][Full Text] [Related]
12. Measuring permeability with a whole cell-based biosensor as an alternate assay for angiogenesis: comparison with common in vitro assays.
Ghosh G; Mehta I; Cornette AL; Anderson KW
Biosens Bioelectron; 2008 Feb; 23(7):1109-16. PubMed ID: 18082392
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation of porcine atelocollagen vitrigel membrane with a spherical curve and transplantable artificial corneal endothelial grafts.
Yoshida J; Oshikata-Miyazaki A; Yokoo S; Yamagami S; Takezawa T; Amano S
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):4975-81. PubMed ID: 25028359
[TBL] [Abstract][Full Text] [Related]
14. Collagen vitrigel: a novel scaffold that can facilitate a three-dimensional culture for reconstructing organoids.
Takezawa T; Ozaki K; Nitani A; Takabayashi C; Shimo-Oka T
Cell Transplant; 2004; 13(4):463-73. PubMed ID: 15468688
[TBL] [Abstract][Full Text] [Related]
15. The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices.
Yao C; Roderfeld M; Rath T; Roeb E; Bernhagen J; Steffens G
Biomaterials; 2006 Mar; 27(8):1608-16. PubMed ID: 16183114
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of silicon nanoporous membranes and ECM-based microenvironments on neurosecretory cells.
Lopez CA; Fleischman AJ; Roy S; Desai TA
Biomaterials; 2006 Jun; 27(16):3075-83. PubMed ID: 16457879
[TBL] [Abstract][Full Text] [Related]
17. Silk fibroin matrices for the controlled release of nerve growth factor (NGF).
Uebersax L; Mattotti M; Papaloïzos M; Merkle HP; Gander B; Meinel L
Biomaterials; 2007 Oct; 28(30):4449-60. PubMed ID: 17643485
[TBL] [Abstract][Full Text] [Related]
18. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
[TBL] [Abstract][Full Text] [Related]
19. VEGF in biological control.
Breen EC
J Cell Biochem; 2007 Dec; 102(6):1358-67. PubMed ID: 17979153
[TBL] [Abstract][Full Text] [Related]
20. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
